Listar por tema "levofloxacin"

Ordenar por:Orden:Resultados:

  • Anti-helicobacter pylori properties of the ant-venom peptide bicarinalin 
    Guzman, J.; Téné, N.; Touchard, A.; Castillo Pareja, Denis Helan; Belkhelfa, H.; Haddioui-Hbabi, L.; Treilhou, M.; Sauvain, Michel Henri Auguste (MDPI, 2018)
    The venom peptide bicarinalin, previously isolated from the ant Tetramorium bicarinatum, is an antimicrobial agent with a broad spectrum of activity. In this study, we investigate the potential of bicarinalin as a novel ...
  • Community-acquired pneumonia in critically ill very old patients: A growing problem 
    Cillóniz, C.; Dominedò, C.; Pericàs, J.M.; Rodriguez-Hurtado, D.; Torres, A. (European Respiratory Society, 2020)
    Very old (aged ≥80 years) adults constitute an increasing proportion of the global population. Currently, this subgroup of patients represents an important percentage of patients admitted to the intensive care unit. ...
  • Increased Doses Lead to Higher Drug Exposures of Levofloxacin for Treatment of Tuberculosis 
    Peloquin, Charles A.; Phillips, Patrick P. J.; Mitnick, Carole D.; Eisenach, Kathleen; Patientia, Ramonde F.; Lecca, Leonid; Gotuzzo Herencia, José Eduardo; Gandhi, Neel R.; Butler, Donna; Diacon, Andreas H.; Martel, Bruno; Santillan, Juan; Hunt, Kathleen Robergeau; Vargas, Dante; von Groote-Bidlingmaier, Florian; Seas Ramos, Carlos Rafael; Dianis, Nancy; Moreno-Martinez, Antonio; Kaur, Pawandeep; Horsburgh, C. Robert (American Society for Microbiology, 2018)
    Patients with multidrug-resistant tuberculosis in Peru and South Africa were randomized to a weight-banded nominal dose of 11, 14, 17, or 20 mg/kg/day levofloxacin (minimum, 750 mg) in combination with other second-line ...
  • Resistant Gram-negative infections in the outpatient setting in Latin America 
    Salles, M.J.C.; Zurita, J.; Mejía, C.; Villegas, M.V.; Alvarez, C.; Bavestrello, L.; Berezin, E.; Gotuzzo Herencia, José Eduardo; Guzmán-Blanco, M.; Labarca, J.A.; Luna, C.M.; Nouer, S.; Rodríguez-Noriega, E.; Seas Ramos, Carlos Rafael (Cambridge University Press, 2013)
    Latin America has a high rate of community-associated infections caused by multidrug-resistant Enterobacteriaceae relative to other world regions. A review of the literature over the last 10 years indicates that urinary ...
  • Treatment outcomes for isoniazid-monoresistant tuberculosis in Peru, 2012-2014 
    Cornejo Garcia, Jose Gabriel; Alarcón Guizado, Valentina Antonieta; Mendoza Ticona, Alberto; Alarcon, Edith; Heldal, Einar; Moore, David Alexander James (Public Library of Science, 2018)
    Background: Resistance to isoniazid is the most common form of drug-resistance in tuberculosis. However only a tiny proportion of TB patients in the world have access to isoniazid drug susceptibility testing—the widely ...

Buscar en el Repositorio

Listar

Panel de Control